Your session is about to expire
← Back to Search
EMPOWER Intervention for Young Adult Cancer Survivors (MOST EMPOWER Trial)
MOST EMPOWER Trial Summary
This trial is testing a digital health intervention to improve wellbeing in young adult cancer survivors. The goal is to learn more about how to promote wellness and manage health-related quality of life among this population.
MOST EMPOWER Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMOST EMPOWER Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MOST EMPOWER Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I finished my cancer treatment less than 5 years ago, not counting maintenance or hormonal therapy.I am currently receiving care to ease symptoms, not cure my disease.I have had cancer before, but not skin cancer.I was diagnosed with my first cancer between 15 and 39 years old and am currently in that age range.
- Group 1: Condition 13
- Group 2: Condition 7
- Group 3: Condition 18
- Group 4: Condition 10
- Group 5: Condition 4
- Group 6: Condition 17
- Group 7: Condition 16
- Group 8: Condition 8
- Group 9: Condition 1
- Group 10: Condition 15
- Group 11: Condition 5
- Group 12: Condition 31
- Group 13: Condition 9
- Group 14: Condition 24
- Group 15: Condition 26
- Group 16: Condition 22
- Group 17: Condition 23
- Group 18: Condition 6
- Group 19: Condition 19
- Group 20: Condition 11
- Group 21: Condition 3
- Group 22: Condition 27
- Group 23: Condition 30
- Group 24: Condition 29
- Group 25: Condition 32
- Group 26: Condition 2
- Group 27: Condition 12
- Group 28: Condition 14
- Group 29: Condition 21
- Group 30: Condition 28
- Group 31: Condition 25
- Group 32: Condition 20
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial accepting elderly participants?
"According to the requirements outlined in this clinical trial's inclusion criteria, only those aged between 15 and 39 are eligible for participation."
Are there any remaining openings to participate in this research?
"Confirmed, the information hosted on clinicaltrials.gov indicates that this medical trial is actively seeking participants. This study was first posted on January 6th 2022 and was most recently updated June 14th 2022; 352 patients are required between two locations to complete enrollment."
What is the intake capacity for this scientific experiment?
"Indeed, the public record on clinicaltrials.gov attests to this medical trial being actively enrolled with 352 individuals needed at two centres. This project was initially logged on January 6th 2022 and underwent its latest amendment on June 14th 2022."
To what demographic is recruitment for this experiment accessible?
"The enrollment criteria for this medical trial requires that prospective participants are between 15-39 years old and have a malignant tumor. Approximately 352 individuals need to be recruited."
Share this study with friends
Copy Link
Messenger